公开(公告)号：US20190021385A1

公开(公告)日：2019-01-24

申请号：US16040704

申请日：2018-07-20

Applicant: Exeltis USA, Inc.

Inventor： Eduardo FERNANDEZ

IPC: A23L33/155 ,  A23L33/12 ,  A23L33/16

Abstract: Orally dissolvable compositions are provided which comprise a nutritional supplement for subjects in physiologically stressful states. The orally dissolvable compositions may comprise one or more water-soluble film strips for oral (buccal or sublingual) administration to a subject. The composition of the nutritional supplement may comprise combinations of vitamin A, vitamin C, vitamin D3, vitamin E, vitamin B1, vitamin B2, niacin, vitamin B6, folic acid, vitamin B12, iron, iodine, magnesium, zinc, copper, omega-3 fatty acids, vitamin D, choline, and one or more flavorants.

公开(公告)号：US20190015429A1

公开(公告)日：2019-01-17

申请号：US15541793

申请日：2016-01-15

Applicant: DSM IP ASSETS B.V.

Inventor： Shuen Ei CHEN ,  Thau Kiong CHUNG ,  Daniel RAEDERSTORFF ,  Wolfgang SCHALCH

IPC: A61K31/593 ,  A23L33/155 ,  A23K20/174 ,  A23K50/75 ,  A23K20/179 ,  A61K31/375 ,  A61K31/355 ,  A61K31/015 ,  A61K31/047 ,  A61K31/01 ,  A61K31/122 ,  A61P15/08 ,  A61P3/04 ,  A61P9/00 ,  A61P3/06 ,  A61P3/10 ,  A61K31/525 ,  A61K31/675 ,  A61K31/455 ,  A61K31/197 ,  A61K31/519 ,  A61K31/4188 ,  A61K33/30 ,  A61K33/34 ,  A61K33/32 ,  A61K33/04

Abstract: This invention relates to the use of the combination of 25-hydroxyvitamin D3 (“25-OH D3”) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian 5 syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.

公开(公告)号：US20180303144A1

公开(公告)日：2018-10-25

申请号：US15770444

申请日：2016-10-24

Applicant: N. V. Nutricia

Inventor： Amos ATTALI

IPC: A23L33/12 ,  A23L33/155 ,  A61K31/202 ,  A61K45/06

CPC classification number: A23L33/12 ,  A23L33/10 ,  A23L33/15 ,  A23L33/155 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2250/1626 ,  A23V2250/1876 ,  A23V2250/304 ,  A23V2250/7052 ,  A23V2250/7058 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/712 ,  A61K31/202 ,  A61K45/06

Abstract: The invention relates to a composition comprising) (i) one or more ω-3 fatty acids selected from the group consisting of DHA, DPA and EPA and (ii) one or more pyrimidine derivatives selected from the group consisting of uridine sources and cytidine sources for use in decreasing or normalizing the phenyl alanine level in the blood of a PKU patient or for use in dietary management of phenylalanine levels in the blood of a PKU patient.

公开(公告)号：US20180256536A1

公开(公告)日：2018-09-13

申请号：US15977390

申请日：2018-05-11

Applicant: ABBOTT LABORATORIES

Inventor： MATTHEW KUCHAN ,  CHRON-SI LAI ,  JACQUELINE BOFF

IPC: A61K31/355 ,  A61K31/047 ,  A61K31/015 ,  A23L33/00 ,  A23L33/15 ,  A23L33/12 ,  A23L33/155

CPC classification number: A61K31/355 ,  A23L33/12 ,  A23L33/15 ,  A23L33/155 ,  A23L33/30 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/01 ,  A61K31/015 ,  A61K31/047 ,  A61K31/065 ,  A61K31/122 ,  A61K2300/00

Abstract: Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed. Methods for improving the development of the visual processing, visual acuity, or both, of an infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed.

公开(公告)号：US20180200287A1

公开(公告)日：2018-07-19

申请号：US15918042

申请日：2018-03-12

Applicant: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.

Inventor： Yoav LIVNEY

IPC: A61K31/732 ,  A61K31/07 ,  A23L29/231 ,  A23L33/105 ,  A61K45/06 ,  A61K31/775 ,  A61K31/592 ,  A61K31/355 ,  A61K31/352 ,  A61K31/122 ,  A61K31/12 ,  A23L33/10 ,  A61K31/05 ,  A61K9/51 ,  A61K9/00 ,  A23L2/52 ,  A23D9/05 ,  A23D7/005 ,  A23L33/155 ,  A23L33/15 ,  B82Y5/00 ,  B82Y30/00 ,  B82Y40/00

CPC classification number: A61K31/732 ,  A23D7/0053 ,  A23D9/05 ,  A23L2/52 ,  A23L29/231 ,  A23L33/10 ,  A23L33/105 ,  A23L33/15 ,  A23L33/155 ,  A23V2002/00 ,  A61K9/0095 ,  A61K9/5161 ,  A61K31/05 ,  A61K31/07 ,  A61K31/12 ,  A61K31/122 ,  A61K31/352 ,  A61K31/355 ,  A61K31/592 ,  A61K31/775 ,  A61K45/06 ,  B82Y5/00 ,  B82Y30/00 ,  B82Y40/00 ,  A61K2300/00

Abstract: This invention provides (a) nanoparticle made of: sugar-beet pectin; and a bioactive compound (such as a nutraceutical or a drug) bound to sugar-beet pectin. The invention further provides foods, beverages, including clear ones, or pharmaceutical preparations, which are supplemented with the nanoparticles made of: sugar-beet pectin; and a hydrophobic bioactive compound bound to sugar-beet pectin. The process of making the nanoparticles of the invention, and methods for supplementing foods or beverages or pharmaceutical preparations with bioactive compounds via the nanoparticles of the invention are also provided.

公开(公告)号：US10016476B2

公开(公告)日：2018-07-10

申请号：US14857576

申请日：2015-09-17

Applicant: BioMarker Pharmaceuticals, Inc.

Inventor： Xi Zhao-Wilson

IPC: A61K36/00 ,  A61K36/82 ,  A61K31/05 ,  A61K36/87 ,  A61K31/352 ,  A61K31/09 ,  A61K31/122 ,  A61K31/385 ,  A61K31/225 ,  A61K31/4745 ,  A61K31/355 ,  A61K31/593 ,  A61K31/5685 ,  C12Q1/6876 ,  A61K31/205 ,  A61K31/221 ,  A61K31/381 ,  A23L33/10 ,  A23L33/105 ,  A23L33/155

CPC classification number: A61K36/82 ,  A23L33/10 ,  A23L33/105 ,  A23L33/155 ,  A23V2002/00 ,  A61K31/05 ,  A61K31/09 ,  A61K31/122 ,  A61K31/205 ,  A61K31/221 ,  A61K31/225 ,  A61K31/352 ,  A61K31/355 ,  A61K31/381 ,  A61K31/385 ,  A61K31/4745 ,  A61K31/5685 ,  A61K31/593 ,  A61K36/00 ,  A61K36/87 ,  C12Q1/6876 ,  C12Q2600/106 ,  C12Q2600/136 ,  C12Q2600/158 ,  A61K2300/00

Abstract: A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.

公开(公告)号：US20180184703A1

公开(公告)日：2018-07-05

申请号：US15740567

申请日：2016-07-01

Applicant: DSM IP ASSETS B.V.

Inventor： Camille ADLER ,  Martin KUENTZ ,  Alexandra TELEKI

IPC: A23P30/20 ,  A23K20/174 ,  A23K20/158 ,  A23K20/179 ,  A23K40/25 ,  A23L33/115 ,  A23L33/155 ,  A23L33/15 ,  A23L33/16 ,  A23K20/28

CPC classification number: A23P30/20 ,  A23K20/158 ,  A23K20/174 ,  A23K20/179 ,  A23K20/28 ,  A23K40/20 ,  A23K40/25 ,  A23L29/015 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23V2002/00

Abstract: The present invention relates to a process for producing specific extruded formulations (=extrudates), wherein the extruded formulations are comprising a high amount of fat-soluble compounds, to such formulations as well as to the use of such formulations in food, feed and personal care applications.

公开(公告)号：US10010098B2

公开(公告)日：2018-07-03

申请号：US13859294

申请日：2013-04-09

Applicant: Ralph Brown

Inventor： Ralph Brown

IPC: A23L1/29 ,  A61K31/07 ,  A61K31/122 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/525 ,  A61K31/592 ,  A61K33/04 ,  A61K33/22 ,  A61K33/24 ,  A61K33/30 ,  A61K45/06 ,  A23L33/00 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16

CPC classification number: A23L33/40 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A61K31/07 ,  A61K31/122 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/525 ,  A61K31/592 ,  A61K33/04 ,  A61K33/22 ,  A61K33/24 ,  A61K33/30 ,  A61K45/06 ,  A61K2300/00

Abstract: A micronutrient dosage unit which comprises two or more micronutrients selected from vitamin A, vitamin B2, vitamin B6, vitamin B9, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, calcium, magnesium, zinc, boron and chromium in one or more specified ratios.

公开(公告)号：US20180169187A1

公开(公告)日：2018-06-21

申请号：US15738215

申请日：2016-06-24

Applicant: Vitalnext B.V.

Inventor： Gerben Carolus Martinus ZONDAG ,  Reinder STRIJKER

IPC: A61K38/17 ,  A23L33/155 ,  A23L33/19 ,  A23L33/175 ,  A23P10/40 ,  A23L33/105 ,  A61K31/56 ,  A61K31/592 ,  A61K31/593 ,  A61K9/00 ,  A61K31/198 ,  A61P3/02

CPC classification number: A61K38/1709 ,  A23L33/10 ,  A23L33/105 ,  A23L33/155 ,  A23L33/175 ,  A23L33/19 ,  A23P10/40 ,  A23V2002/00 ,  A61K9/0095 ,  A61K31/198 ,  A61K31/56 ,  A61K31/592 ,  A61K31/593 ,  A61P3/02

Abstract: The present invention relates to novel liquid or semi-liquid nutritional compositions, and powders to generate such liquid or semi-liquid nutritional compositions, that are beneficial in the treatment of malnutrition and malnutrition-related disorders such as weight loss and muscle wasting. When administered regularly, the nutritional compositions according to the present invention contribute to the reversal of malnutrition and malnutrition-related disorders such as weight loss and/or muscle atrophy.

公开(公告)号：US20180153947A1

公开(公告)日：2018-06-07

申请号：US15317603

申请日：2015-06-11

Applicant: BIOCODEX

Inventor： Jean-Marie LEFEVRE ,  Gilles RENAUD ,  Marie-Emmanuelle LE GUERN

IPC: A61K36/064 ,  A61J1/20 ,  A61J7/00 ,  A61K9/19 ,  A61K47/26 ,  A61K47/12 ,  A61P1/12 ,  A23L33/14 ,  A23L33/16 ,  A23L33/155 ,  A23L33/125

CPC classification number: A61K36/064 ,  A23L33/125 ,  A23L33/14 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23P10/40 ,  A23V2002/00 ,  A61J1/2093 ,  A61J7/0046 ,  A61K9/19 ,  A61K47/12 ,  A61K47/26 ,  A61P1/12

Abstract: The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylized Saccharomyces boulardii as an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilized S. boulardii powder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension of S. boulardii to be administered to an individual upon opening of the vial.